Leukoaraiosis is associated with genes regulating blood-brain barrier homeostasis in ischaemic stroke patients

European Journal of Neurology

Volumn 18, Issue 6, 2011, Pages 826-835

  Fernandez Cadenas, I ^a,b   Mendioroz, M ^a,b   Domingues Montanari, S ^a,b   Del Rio Espinola, A ^a,b   Delgado, P ^a,b   Ruiz, A ^c   Hernandez Guillamon, M ^a,b   Giralt, D ^a,b   Chacon, P ^a   Navarro Sobrino, M ^a,b   Ribo, M ^a,b   Molina, C A ^a,b   Alvarez Sabin, J ^a,b   Rosell, A ^a,b   Montaner, J ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Structural Genomics Neocodex Department   (Spain)

Author keywords

Genetics; Leukoaraiosis; Stroke; White matter hyperintensities

Indexed keywords

ALPHA 2 MACROGLOBULIN; ARYLDIALKYLPHOSPHATASE 1; BETA6 INTEGRIN; COLLAGENASE 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 5 RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE PATIENT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HOMEOSTASIS; HUMANS; INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT; LEUKOARAIOSIS; MALE; MIDDLE AGED; RISK FACTORS; STROKE;

EID: 79955708432     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03243.x     Document Type: Article

References (42)

1. Breteler MM, van Amerongen NM, van Swieten JC, et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke 1994; 25: 1109-1115.
2. Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study. The Rotterdam Study. Neurology 1994; 44: 1246-1252.
3. George AE, de Leon MJ, Gentes CI, et al. Leukoencephalopathy in normal and pathological aging. CT of brain lucencies. AJNR Am J Neuroradiol 1986; 7: 561-566.
4. Ostrow PT, Miller LL. Pathology of small artery disease. Adv Neurol 1993; 62: 93-123.
5. The Dutch TIA Trial Study Group. Predictors of major vascular events in patients with a transient ischemic attack or nondisabling stroke. Stroke 1993; 24: 527-531.
6. van Swieten JC, Kappelle LJ, Algra A, et al., for the Dutch TIA Trial Study Group. Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Ann Neurol 1992; 32: 177-183.
7. Turner ST, Fornage M, Jack CR Jr, et al. Genomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibships. Arch Neurol 2009; 7: 847-857.
8. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
9. Hassan A, Lansbury A, Catto AJ, et al. Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes. J Neurol Neurosurg Psychiatry 2002; 3: 343-346.
10. Schmidt R, Fazekas F, Enzinger C, et al. Risk factors and progression of small vessel disease-related cerebral abnormalities. J Neural Transm Suppl 2002; 62: 47-52.
11. Szolnoki Z, Somogyvari F, Kondacs A, et al. Evaluation of the roles of common genetic mutations in leukoaraiosis. Acta Neurol Scand 2001; 5: 281-287.
12. Leung CH, Poon WS, Yu LM, et al. Apolipoprotein E genotype and outcome in aneurysmal subarachnoid hemorrhage. Stroke 2002; 33: 548-552.
13. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993; 24: 35-41.
14. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging. AJNR Am J Neuroradiol 1987; 8: 421-426.
15. Wahlund LO, Barkhof F, Fazekas F, et al. European Task Force on Age-Related White Matter Changes.A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001; 6: 1318-1322.
16. Gayán J, González-Pérez A, Bermudo F, et al. A method for detecting epistasis in genome-wide studies using case-control multi-locus association analysis. BMC Genomics 2008; 9: 360.
17. Calvano SE, Xiao W, Richards DR, et al. A network-based analysis of systemic inflammation in humans. Nature 2005; 437: 1032-1037.
18. Topakian R, Barrick TR, Howe FA, et al. Blood-brain barrier permeability is increased in normal appearing white matter in patients with lacunar stroke and leukoaraiosis. J Neurol Neurosurg Psychiatry 2009; 81: 192-197.
19. Montaner J, Molina CA, Monasterio J, et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 2003; 4: 598-603.
20. Saunders AJ, Bertram L, Mullin K, et al. Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin. Hum Mol Genet 2003; 21: 2765-2776.
21. Rosell A, Alvarez-Sabín J, Arenillas JF, et al. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke. Stroke 2005; 7: 1415-1420.
22. Cuadrado E, Rosell A, Borrell-Pagès M, et al. Matrix metalloproteinase-13 is activated and is found in the nucleus of neural cells after cerebral ischemia. J Cereb Blood Flow Metab 2009; 2: 398-410.
23. Fornage M, Mosley TH, Jack CR, et al. Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury. Hum Genet 2007; 5: 671-680.
24. Chen HH, Wang DL. Nitric oxide inhibits matrix metalloproteinase-2 expression via the induction of activating transcription factor 3 in endothelial cells. Mol Pharmacol 2004; 5: 1130-1140.
25. Matsunaga T, Weihrauch DW, Moniz MC, et al. Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation 2002; 105: 2185-2191.
26. Eberhardt W, Beeg T, Beck KF, et al. Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kidney Int 2002; 57: 59-69.
27. Gu Z, Kaul M, Yan B, et al. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science (Wash DC) 2002; 297: 1186-1190.
28. Kollintza A, Worthington J, John S, et al. A new polymorphism in the promoter of the interleukin 5 receptor alpha subunit (IL-5RA) gene. Immunogenetics 1998; 1: 65-66.
29. Birjmohun RS, Vergeer M, Stroes ES, et al. Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study. PLoS ONE 2009; 8: e6809.
30. Watson AD, Berliner JA, Hama SY, et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995; 6: 2882-2891.
31. Bhattacharyya T, Nicholls SJ, Topol EJ, et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 2008; 11: 1265-1276.
32. Wills AM, Cronin S, Slowik A, et al. A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology 2009; 73: 16-24.
33. Dedhar S. Integrins and signal transduction. Curr Opin Hematol 1999; 6: 37-43.
34. Holly SP, Larson MK, Parise LV. Multiple roles of integrins in cell motility. Exp Cell Res 2000; 261: 60-74.
35. Breuss JM, Gillett N, Lu L, Sheppard D, et al. Restricted distribution of integrin β6 mRNA in primate epithelial tissues. J Histochem Cytochem 1993; 41: 1521-1527.
36. Zhao-Yang Z, Ke-Sen X, Qing-Si H, et al. Signaling and regulatory mechanisms of integrin alphavbeta6 on the apoptosis of colon cancer cells. Cancer Lett 2008; 2: 209-215.
37. Niu J, Gu X, Turton J, et al. Integrin mediated signaling of gelatinase B secretion in colon carcinoma cells. Biochem Biophys Res Commun 1998; 249: 287-291.
38. Ridgway PF, Ziprin P, Peck DH, et al. Hypoxia increases reepithelialization via an alphavbeta6-dependent pathway. Wound Repair Regen 2005; 2: 158-164.
39. Haqqani AS, Nesic M, Preston E, et al. Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS. FASEB J 2005; 13: 1809-1821.
40. Haqqani AS, Kelly J, Baumann E, Haseloff RF, et al. Protein markers of ischemic insult in brain endothelial cells identified using 2D gel electrophoresis and ICAT-based quantitative proteomics. J Proteome Res 2007; 6: 226-239.
41. Lu C, Pelech S, Zhang H, et al. Pertussis toxin induces angiogenesis in brain microvascular endothelial cells. J Neurosci Res 2008; 86: 2624-2640.
42. Cucullo L, Marchi N, Marroni M, et al. Blood-brain barrier damage induces release of alpha2-macroglobulin. Mol Cell Proteomics 2003; 2: 234-241.